AKT1 and neoplasm: Exosomal Ribosomal Protein S3 (RPS3) secreted by cisplatin-resistant tumor cells could be taken up by cisplatin-sensitive cells and thus become chemo resistant (through activation of the PI3K-Akt-cofilin-1 signaling pathway), indicating its potential value for proper chemotherapeutics selection (58).